Heterocyclic alkylphospholipids with an improved therapeutic range

Advances in Experimental Medicine and Biology

Volumn 416, Issue , 1997, Pages 157-164

  Hilgard, P ^a   Stekar, J ^a   Klenner, T ^a   Nossner G ^a   Kutscher, B ^a   Engel, J ^a  

^a ASTA MEDICA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; D 20133; DIMETHYLBENZ[A]ANTHRACENE; DOXORUBICIN; HETEROCYCLIC COMPOUND; MILTEFOSINE; PERIFOSINE; PHOSPHOLIPID; PHOSPHORYLCHOLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; BODY WEIGHT; BREAST CARCINOMA; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG STRUCTURE; GASTROINTESTINAL TOXICITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

ANIMALIA;

EID: 0030938280     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (6)

1. Burk, K., David, M., Junge, K., Sindermann, H. Overview on the clinical development of miltefosine solution (Miltex®) for the treatment of cutaneous breast cancer. Drugs of Today 30, (Suppl. B): 59-72, 1994
2. Verweij, J., Gandia, D., Planting, A.S.Th., Stoter, G., Armand, J.P. Phase II study of oral miltefosine in patients with squamous cell head and neck cancer. Eur. J. Cancer 29A, 778-779, 1993
3. Stekar, J., Hilgard, P., Klenner, T., Noessner, G., Schumacher, W. A second generation of alkylphospholipids with high antineoplastic activity. Proc. Amer. Ass. Cancer Res. 34: 335 (Abstr. 1996), 1993
4. Stekar, J., Hilgard, P., Voegeli, R., Maurer, R., Engel, J., Kutscher, B., Noessner, G., Schumacher, W. Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-20133. Cancer Chemother. Pharmacol. 32: 437-444, 1993
5. Spruss, T., Bernhardt, G., Reile, H., Schönenberger, H., Engel, J. Combination therapy with platinum complexes and hexadecylphosphocholine of MXT mouse mammary adenocarcinomas. (Abstr. TH10), J. Cancer Res. Clin. Oncol. 115:55, 1989
6. Beckers, T., Voegeli, R. Molecular targets of miltefosine. Drugs of Today 30 (Suppl. B): 5-12, 1994